<html><body><b><i>Business Combinations </i></b><p style="margin-top:0px;margin-bottom:-6px"><font size="1"></font></p><p style="margin-top:0px;margin-bottom:0px; text-indent:4%"><font size="2" style="font-family:Times New Roman">We allocate the purchase price of acquired businesses to the
tangible and intangible assets acquired and liabilities assumed based upon their estimated fair values on the acquisition date. The purchase price allocation process requires management to make significant estimates and assumptions, especially at
acquisition date with respect to intangible assets and in-process research and development. </font></p><p style="margin-top:0px;margin-bottom:0px"><font size="1"></font></p><p align="center" style="margin-top:0px;margin-bottom:0px"><font size="2" style="font-family:Times New Roman">39 </font></p><p style="page-break-before:always">
</p><hr align="CENTER" size="3" style="COLOR:#999999" width="100%"/><h5 align="left"><a href="#toc">Table of Contents</a></h5><p style="margin-top:0px;margin-bottom:0px; text-indent:4%"><font size="2" style="font-family:Times New Roman">Although we believe the assumptions and estimates made are reasonable, they are based in
part on historical experience and information obtained from the management of the acquired businesses and are inherently uncertain. Examples of critical estimates in valuing certain of the intangible assets we have acquired or may acquire in the
future include but are not limited to: </font></p><p style="margin-top:0px;margin-bottom:-6px"><font size="1"></font></p><table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE" width="100%">
<tr>
<td width="4%"><font size="1"></font></td>
<td align="left" valign="top" width="2%"><font size="2" style="font-family:Times New Roman"></font></td>
<td valign="top" width="1%"></td>
<td align="left" valign="top"> <p align="left"><font size="2" style="font-family:Times New Roman">the feasibility and timing of achievement of development, regulatory and commercial milestones; </font></p></td></tr></table><tr>
<td width="4%"><font size="1"></font></td>
<td align="left" valign="top" width="2%"><font size="2" style="font-family:Times New Roman"></font></td>
<td valign="top" width="1%"></td>
<td align="left" valign="top"> <p align="left"><font size="2" style="font-family:Times New Roman">the feasibility and timing of achievement of development, regulatory and commercial milestones; </font></p></td></tr><td width="4%"><font size="1"></font></td><td align="left" valign="top" width="2%"><font size="2" style="font-family:Times New Roman"></font></td><td valign="top" width="1%"></td><td align="left" valign="top"> <p align="left"><font size="2" style="font-family:Times New Roman">the feasibility and timing of achievement of development, regulatory and commercial milestones; </font></p></td><p align="left"><font size="2" style="font-family:Times New Roman">the feasibility and timing of achievement of development, regulatory and commercial milestones; </font></p><p style="margin-top:0px;margin-bottom:-6px"><font size="1"></font></p><table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE" width="100%">
<tr>
<td width="4%"><font size="1"></font></td>
<td align="left" valign="top" width="2%"><font size="2" style="font-family:Times New Roman"></font></td>
<td valign="top" width="1%"></td>
<td align="left" valign="top"> <p align="left"><font size="2" style="font-family:Times New Roman">expected costs to develop the in-process research and development into commercially viable products; and </font></p></td></tr></table><tr>
<td width="4%"><font size="1"></font></td>
<td align="left" valign="top" width="2%"><font size="2" style="font-family:Times New Roman"></font></td>
<td valign="top" width="1%"></td>
<td align="left" valign="top"> <p align="left"><font size="2" style="font-family:Times New Roman">expected costs to develop the in-process research and development into commercially viable products; and </font></p></td></tr><td width="4%"><font size="1"></font></td><td align="left" valign="top" width="2%"><font size="2" style="font-family:Times New Roman"></font></td><td valign="top" width="1%"></td><td align="left" valign="top"> <p align="left"><font size="2" style="font-family:Times New Roman">expected costs to develop the in-process research and development into commercially viable products; and </font></p></td><p align="left"><font size="2" style="font-family:Times New Roman">expected costs to develop the in-process research and development into commercially viable products; and </font></p><p style="margin-top:0px;margin-bottom:-6px"><font size="1"></font></p><table border="0" cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE" width="100%">
<tr>
<td width="4%"><font size="1"></font></td>
<td align="left" valign="top" width="2%"><font size="2" style="font-family:Times New Roman"></font></td>
<td valign="top" width="1%"></td>
<td align="left" valign="top"> <p align="left"><font size="2" style="font-family:Times New Roman">future expected cash flows from product sales; </font></p></td></tr></table><tr>
<td width="4%"><font size="1"></font></td>
<td align="left" valign="top" width="2%"><font size="2" style="font-family:Times New Roman"></font></td>
<td valign="top" width="1%"></td>
<td align="left" valign="top"> <p align="left"><font size="2" style="font-family:Times New Roman">future expected cash flows from product sales; </font></p></td></tr><td width="4%"><font size="1"></font></td><td align="left" valign="top" width="2%"><font size="2" style="font-family:Times New Roman"></font></td><td valign="top" width="1%"></td><td align="left" valign="top"> <p align="left"><font size="2" style="font-family:Times New Roman">future expected cash flows from product sales; </font></p></td><p align="left"><font size="2" style="font-family:Times New Roman">future expected cash flows from product sales; </font></p><p style="margin-top:0px;margin-bottom:0px"><font size="1"></font></p><p style="margin-top:0px;margin-bottom:0px; text-indent:4%"><font size="2" style="font-family:Times New Roman">In connection with the purchase price allocations for acquisitions, we estimate the fair value of the
contingent payments. The estimated fair value of any contingent payments is determined utilizing a probability-based income approach inclusive of an estimated discount rate. </font></p></body></html>